Challenges and Opportunities in NASH Drug DevelopmentStephen A. Harrison & Alina M. Allen & Julie Dubourg & Mazen Noureddin & Naim Alkhouri2023PDF2.2 MB
Cardiac and Liver Impairment on Multiorgan MRI and Risk of Major Adverse Cardiovascular and Liver EventsEdward Jackson & Andrea Dennis & Naim Alkhouri & Niharika Samala & Raj Vuppalanchi & Arun J. Sanyal & Mark Muthiah & Rajarshi Banerjee & Amitava Banerjee2025PDF2.6 MB
Resmetirom for Nonalcoholic Fatty Liver DiseaseStephen A. Harrison & Rebecca Taub & Guy W. Neff & K. Jean Lucas & Dominic Labriola & Sam E. Moussa & Naim Alkhouri & Mustafa R. Bashir2023PDF5.0 MB
Antisense Oligonucleotide DGAT-2 Inhibitor, ION224, for Metabolic Dysfunction-associated Steatohepatitis (ION224-CS2)Prof Rohit Loomba MD & Erin Morgan Bs & Keyvan Yousefi PhD & Dan Li PhD & Richard Geary PhD & Sanjay Bhanot MD & Naim Alkhouri MD & ION224-CS2 Investigators2025PDF665 KB
TERN-501 Monotherapy and Combination Therapy with TERN-101 in Metabolic Dysfunction-associated SteatohepatitisMazen Noureddin & Naim Alkhouri & Eric J. Lawitz & Kris V. Kowdley & Rohit Loomba & Lois Lee & Christopher Jones & Amnon Schlegel & Tonya Marmon & Kacey Anderson & Yizhao Li & Erin Quirk & Stephen A. Harrison2025PDF2.9 MB
Long-term Liver Outcomes After Metabolic Surgery in Compensated Cirrhosis Due to Metabolic Dysfunction-associated SteatohepatitisAli Aminian & Abdullah Aljabri & Sarah Wang & James Bena & Daniela S. Allende & Hana Rosen & Eileen Arnold & Rickesha Wilson & Alex Milinovich & Rohit Loomba & Arun J. Sanyal & Naim Alkhouri & Jamile Wakim-Fleming & Sobia N. Laique & Srinivasan...2025PDF3.7 MB
